![]() Soligenix Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases. | ||
Founding Date | Founding Date 1987 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Princeton, US HQ | Locations London, GB HQ Basel, CH Boston, US New York, US |
Employees | Employees 1422% decrease | Employees 908 |
Valuation ($) | Valuation ($) 8.7 m | Valuation ($) 8.8 b |
Financial | ||
Net income | Net income ($11.1m) (FY, 2025) | Net income ($397.9m) (FY, 2025) |

Roivant Sciences is a company that develops and commercializes medicines.
View company